Tchivileva Inna E, Tan Kai Soo, Gambarian Maria, Nackley Andrea G, Medvedev Alexander V, Romanov Sergei, Flood Patrick M, Maixner William, Makarov Sergei S, Diatchenko Luda
The Center for Neurosensory Disorders, School of Dentistry, University of North Carolina, Chapel Hill, NC 27599, USA.
Mol Immunol. 2009 Jul;46(11-12):2256-66. doi: 10.1016/j.molimm.2009.04.008. Epub 2009 May 23.
The beta(3)-adrenergic receptor (beta(3)AR) is an essential regulator of metabolic and endocrine functions. A major cellular and clinically significant consequence of beta(3)AR activation is the substantial elevation in interleukin-6 (IL-6) levels. Although the beta(3)AR-dependent regulation of IL-6 expression is well established, the cellular pathways underlying this regulation have not been characterized. Using a novel method of homogenous reporters, we assessed the pattern of activation of 43 transcription factors in response to the specific beta(3)AR agonist CL316243 in adipocytes, cells that exhibit the highest expression of beta(3)ARs. We observed a unique and robust activation of the CRE-response element, suggesting that IL-6 transcription is regulated via the G(s)-protein/cAMP/protein kinase A (PKA) but not nuclear factor kappa B (NF-kappaB) pathway. However, pretreatment of adipocytes with pharmacologic inhibitors of PKA pathway failed to block beta(3)AR-mediated IL-6 up-regulation. Additionally, stimulation of adipocytes with the exchange protein directly activated by cAMP (Epac) agonist did not induce IL-6 expression. Instead, the beta(3)AR-mediated transcription of IL-6 required activation of both the p38 and PKC pathways. Western blot analysis further showed that transcription factors CREB and ATF-2 but not ATF-1 were activated in a p38- and PKC-dependent manner. Collectively, our results suggest that while stimulation of the beta(3)AR leads to a specific activation of CRE-dependent transcription, there are several independent cellular pathways that converge at the level of CRE-response element activation, and in the case of IL-6 this activation is mediated by p38 and PKC but not PKA pathways.
β(3)-肾上腺素能受体(β(3)AR)是代谢和内分泌功能的重要调节因子。β(3)AR激活的一个主要细胞及临床显著后果是白细胞介素-6(IL-6)水平大幅升高。尽管β(3)AR依赖的IL-6表达调节已得到充分证实,但该调节的细胞途径尚未明确。我们使用一种新型的均相报告基因方法,评估了43种转录因子在脂肪细胞(β(3)AR表达最高的细胞)中对特异性β(3)AR激动剂CL316243的激活模式。我们观察到CRE反应元件有独特且强烈的激活,这表明IL-6转录是通过G(s)蛋白/cAMP/蛋白激酶A(PKA)而非核因子κB(NF-κB)途径调节的。然而,用PKA途径的药理抑制剂预处理脂肪细胞未能阻断β(3)AR介导的IL-6上调。此外,用cAMP直接激活的交换蛋白(Epac)激动剂刺激脂肪细胞并未诱导IL-6表达。相反,β(3)AR介导的IL-6转录需要p38和PKC途径的激活。蛋白质印迹分析进一步表明,转录因子CREB和ATF-2而非ATF-1以p38和PKC依赖的方式被激活。总体而言,我们的结果表明,虽然β(3)AR刺激导致CRE依赖转录的特异性激活,但有几条独立的细胞途径在CRE反应元件激活水平汇聚,就IL-6而言,这种激活是由p38和PKC而非PKA途径介导的。